Why is Sanofi India falling/rising?

As of 12-Sep, Sanofi India Ltd's stock price is currently at 5,069.50, reflecting a decrease of 6.5 points or 0.13%. The stock has underperformed its sector by 0.42% today and has experienced a trend reversal, falling after two consecutive days of gains. It is trading below all key moving averages, indicating a bearish trend. Over the past year, the stock has generated a return of -29.73%, significantly underperforming the BSE500 index, which has seen a decline of only 1.28%. The company's financials reveal a concerning picture, with net sales and operating profit declining over the last five years, and recent quarterly results showing substantial drops in both profit before tax and profit after tax compared to previous averages.
In the broader market context, Sanofi India's short-term performance has been notably weaker than the benchmark, with a 1-week return of -0.60% compared to the Sensex's gain of 1.48%. This underperformance is compounded by a decline in investor participation, as evidenced by a 5.29% drop in delivery volume against the 5-day average. While the company boasts high management efficiency and a low debt-to-equity ratio, these positives are overshadowed by poor long-term growth prospects and a significant decline in profits. The stock's premium valuation relative to peers further complicates its attractiveness, leading to a cautious outlook among investors.